M
Maja Cemazar
Researcher at University of Primorska
Publications - 264
Citations - 9850
Maja Cemazar is an academic researcher from University of Primorska. The author has contributed to research in topics: Electrochemotherapy & Electroporation. The author has an hindex of 48, co-authored 230 publications receiving 8420 citations. Previous affiliations of Maja Cemazar include University of Ljubljana & European Organisation for Research and Treatment of Cancer.
Papers
More filters
Journal ArticleDOI
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
Michel Marty,Gregor Sersa,Jean Rémi Garbay,Julie Gehl,C. Collins,Marko Snoj,Valérie Billard,Poul F. Geertsen,J. Larkin,Damijan Miklavčič,Ivan Pavlović,Snezna M. Paulin-Kosir,Maja Cemazar,Nassim Morsli,Declan M. Soden,Z Rudolf,Caroline Robert,Gerald C. O'Sullivan,Lluis M. Mir,Lluis M. Mir +19 more
TL;DR: Evaluated and confirmed efficacy and safety of electrochemotherapy with bleomycin or cisplatin on cutaneous and subcutaneous tumour nodules of patients with malignant melanoma and other malignancies in a multicenter study.
Journal ArticleDOI
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy.
Lluis M. Mir,Glass Lf,Gregor Sersa,Justin Teissié,Christian Domenge,Damijan Miklavčič,Mark J. Jaroszeski,Stéphane Orlowski,Douglas S. Reintgen,Z Rudolf,M. Belehradek,Richard Gilbert,Marie-Pierre Rols,J. Belehradek,Jean-Marc Bachaud,Ronald C. DeConti,Borut Štabuc,Maja Cemazar,P Coninx,Richard Heller +19 more
TL;DR: ECT was shown to be an effective local treatment and was effective regardless of the histological type of the tumour, and offers an approach to the treatment of cutaneous and subcutaneous tumours in patients with minimal adverse side-effects and with a high response rate.
Journal ArticleDOI
Electrochemotherapy in treatment of tumours.
TL;DR: Electrochemotherapy is a new, clinically acknowledged method for the treatment of cutaneous and subcutaneous tumours whose advantages are high effectiveness on tumours with different histologies, simple application, minimal side effects and the possibility of effective repetitive treatment.
Journal Article
Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
Gillian M. Tozer,Vivien E. Prise,John T. Wilson,Maja Cemazar,Siqing Shan,Mark W. Dewhirst,Paul R. Barber,Borivoj Vojnovic,David J. Chaplin +8 more
TL;DR: The tumor vascular effects of the tubulin destabilizing agent disodium combretastatinA-4 3-O-phosphate (CA-4-P) were investigated in the rat P22 tumor growing in a dorsal skin flap window chamber implanted into BD9 rats, and results suggest a mechanism of action of CA- 4-P in vivo.
Journal Article
Electrochemotherapy with Cisplatin: Clinical Experience in Malignant Melanoma Patients
TL;DR: The results clearly demonstrate that electrochemotherapy with cisplatin is a highly effective approach for treatment of cutaneous malignant melanoma nodules, and the advantages of this therapy include its simplicity, the short duration of treatment sessions, low cisPlatin doses, and insignificant side effects.